SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of ...
Posters presented at the American Society for Reproductive Medicine 2023 Scientific Congress & Expo highlighted trends in fertility care amid the turbulent landscape following the Dobbs decision.
The American Society for Reproductive Medicine (ASRM) is a non-profit organization that provides education, research, and advocacy in the field of reproductive medicine. The organization was founded ...
Two posters presented at the American Society for Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo showed trends in funding and insurance coverage for individuals seeking fertility care.
Please provide your email address to receive an email when new articles are posted on . More research is needed for preimplantation genetic testing for polygenic disorders. Now, it cannot account for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results